Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year? [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
The drugmaker had been a relatively small and unknown player in the industry. However, Viking's prominence and stock price soared thanks to excellent clinical progress. The biotech's shares are up by 154% since early January. Can Viking Therapeutics perform nearly as well during the second half of the year? Is it already too late to buy the stock? Let's find out. Why Viking Therapeutics has been on fire Viking's lead asset is VK2735, a potential weight loss therapy. Given how successful anti-obesity medicines like Wegovy (developed by Novo Nordisk ) and Zepbound (marketed by Eli Lilly ) have become, many companies are pouring funds into this area, trying to develop candidates that can compete with the leaders in the field. Among this herd of drugmakers -- outside of Eli Lilly and Novo Nordisk -- Viking Therapeutics has, so far, been the most impressive. In a phase 2 study, VK2735 proved highly effective at reducing body weight, a result which sent Viking Therapeutics' shares s
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know [Yahoo! Finance]Yahoo! Finance
- Several Factors Negatively Impacted Viking Therapeutics (VKTX) in Q2 [Yahoo! Finance]Yahoo! Finance
- Viking Surges 342% in the Past Year: How Should You Play the Stock? [Yahoo! Finance]Yahoo! Finance
- The Best Biotech Stock to Invest $1,000 in Right Now [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics: GLP-1/GIP Receptor Agonist And Its Competitive Landscape [Seeking Alpha]Seeking Alpha
VKTX
Earnings
- 7/24/24 - Beat
VKTX
Sec Filings
- 8/22/24 - Form 4
- 8/22/24 - Form 4
- 8/21/24 - Form 144
- VKTX's page on the SEC website